Darci J. Trader
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
Publications
76
Citations
1,148
Est. group size
~5
Recurring co-author estimate
Active years
21
Publishing since 2006
Darci J. Trader's lab studies the proteasome, the cell's protein-disposal machinery, focusing on how to activate or inhibit its activity for therapeutic purposes. Their work includes designing small molecules and 'degrader' compounds that either boost proteasome function (potentially protecting cells from stress-related damage) or direct it to destroy specific disease-related proteins, such as through novel targeted protein degradation strategies. This research spans chemical synthesis, structural biology, and cell biology techniques including NMR and live imaging.
Publication output has grown substantially in recent years, rising from a handful of papers per year in the late 2010s to a peak of over a dozen annually in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Increasing Proteasome Activity to Alter XBP1 Signaling of the UPR Pathway
ChemBioChem · 2026
- You are what you degrade: tracking the cellular fates of the proteasomal degradome
Molecular Omics · 2026
- <i>In Vivo</i> Time-Lapse Imaging Reveals Differential Activity-Induced Regulation of Proteasome Activity in Subcellular Regions of the Optic Tectum in <i>Xenopus laevis</i> Tadpoles
ACS Chemical Neuroscience · 2026
- Two Mechanisms One Molecule: Developing a ‘Truly’ Bifunctional Degrader Targeting Rpn13 and CRBN
Journal of the American Chemical Society · 2026
- ByeTAC: Bypassing E-Ligase-Targeting Chimeras for Direct Proteasome Degradation
Journal of Medicinal Chemistry · 2025
- Immunoproteasome as a Target for Prodrugs
Journal of Medicinal Chemistry · 2025
- Degradation of Abl Utilizing an Immunoproteasome N-Degron Prodrug
Journal of Medicinal Chemistry · 2025
- NMR-Guided Studies to Establish the Binding Interaction between a Peptoid and Protein
Journal of the American Chemical Society · 2025
- Synthesis and Application of BRD4‐Targeting ByeTACs (Bypassing E‐Ligase Targeting Chimeras)
Current Protocols · 2025
- Activation of the 20S proteasome core particle prevents cell death induced by oxygen- and glucose deprivation in cultured cortical neurons
APOPTOSIS · 2025
- Exploring the immunoproteasome's substrate preferences for improved hydrolysis and selectivity
RSC Chemical Biology · 2025
- Oleanolic Acid Amide Derivatives as 20s Proteasome Stimulators
ChemBioChem · 2025
- From Breakdown to Breakthrough: Immunoproteasomes Could Revolutionize Immunotherapies
Journal of Medicinal Chemistry · 2025
- Small molecule proteasome activation: comparative structural analysis of known stimulators
Bioorganic & Medicinal Chemistry · 2025
- Synthesis of Immunoproteasome N‐Degron Prodrugs for Selective Protein Degradation
Current Protocols · 2025
- ChemBioChem×9
- Journal of Medicinal Chemistry×6
- ChemRxiv×6
- Current Protocols×4
- Journal of the American Chemical Society×3
- Christine S. Muli
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Rishi Patel
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Cody A. Loy
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Joseph Mills
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kankan Wang
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile